The role and mechanisms of microvascular damage in the ischemic myocardium.

Li Y, Schoufour J, Wang DD et al (2020) Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ 368:l6669. https://doi.org/10.1136/bmj.l6669

doi: 10.1136/bmj.l6669 pubmed: 31915124 pmcid: 7190036

Bhatnagar A (2017) Environmental determinants of cardiovascular disease. Circ Res 121(2):162–180. https://doi.org/10.1161/CIRCRESAHA.117.306458

doi: 10.1161/CIRCRESAHA.117.306458 pubmed: 28684622 pmcid: 5777598

Wang W, Hu M, Liu H et al (2021) Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease. Cell Metab 33(10):1943-1956e1942. https://doi.org/10.1016/j.cmet.2021.08.005

doi: 10.1016/j.cmet.2021.08.005 pubmed: 34478633

Balakumar P, Maung UK, Jagadeesh G (2016) Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res 113(Pt A):600–609. https://doi.org/10.1016/j.phrs.2016.09.040

doi: 10.1016/j.phrs.2016.09.040 pubmed: 27697647

Organization WH (2021) Cardiovascular diseases (CVDs). Retrieved from https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds ). Accessed 14 Feb 2023

Roth GA, Mensah GA, Johnson CO et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol 76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010

doi: 10.1016/j.jacc.2020.11.010 pubmed: 33309175 pmcid: 7755038

Smit M, Coetzee AR, Lochner A (2020) The pathophysiology of myocardial ischemia and perioperative myocardial infarction. J Cardiothorac Vasc Anesth 34(9):2501–2512. https://doi.org/10.1053/j.jvca.2019.10.005

doi: 10.1053/j.jvca.2019.10.005 pubmed: 31685419

Mozaffarian D, Benjamin EJ, Go AS et al (2015) Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131(4):e29-322. https://doi.org/10.1161/CIR.0000000000000152

doi: 10.1161/CIR.0000000000000152 pubmed: 25520374

Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J 35(17):1101–1111. https://doi.org/10.1093/eurheartj/eht513

doi: 10.1093/eurheartj/eht513 pubmed: 24366916

Chang X, Lochner A, Wang HH et al (2021) Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control. Theranostics 11(14):6766–6785. https://doi.org/10.7150/thno.60143

doi: 10.7150/thno.60143 pubmed: 34093852 pmcid: 8171103

Kleinbongard P, Heusch G (2022) A fresh look at coronary microembolization. Nat Rev Cardiol 19(4):265–280. https://doi.org/10.1038/s41569-021-00632-2

doi: 10.1038/s41569-021-00632-2 pubmed: 34785770

Zhong J, Ouyang H, Sun M et al (2019) Tanshinone IIA attenuates cardiac microvascular ischemia-reperfusion injury via regulating the SIRT1-PGC1alpha-mitochondrial apoptosis pathway. Cell Stress Chaperones 24(5):991–1003. https://doi.org/10.1007/s12192-019-01027-6

doi: 10.1007/s12192-019-01027-6 pubmed: 31388827 pmcid: 6717231

Khuddus MA, Pepine CJ, Handberg EM et al (2010) An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). J Interv Cardiol 23(6):511–519. https://doi.org/10.1111/j.1540-8183.2010.00598.x

doi: 10.1111/j.1540-8183.2010.00598.x pubmed: 21029178

Reynolds HR, Diaz A, Cyr DD et al (2023) Ischemia with nonobstructive coronary arteries: insights from the ISCHEMIA Trial. JACC Cardiovasc Imaging 16(1):63–74. https://doi.org/10.1016/j.jcmg.2022.06.015

doi: 10.1016/j.jcmg.2022.06.015 pubmed: 36115814

Camici PG, Crea F (2007) Coronary microvascular dysfunction. N Engl J Med 356(8):830–840. https://doi.org/10.1056/NEJMra061889

doi: 10.1056/NEJMra061889 pubmed: 17314342

Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 118(10):1643–1658. https://doi.org/10.1161/CIRCRESAHA.116.308640

doi: 10.1161/CIRCRESAHA.116.308640 pubmed: 27174955

Lambert L, Brown K, Segal E et al (2010) Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 303(21):2148–2155. https://doi.org/10.1001/jama.2010.712

doi: 10.1001/jama.2010.712 pubmed: 20516415

He J, Bellenger NG, Ludman AJ et al (2022) Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope. Rev Cardiovasc Med 23(1):23. https://doi.org/10.31083/j.rcm2301023

doi: 10.31083/j.rcm2301023 pubmed: 35092215

Wu S, Chang G, Gao L et al (2018) Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. J Mol Med (Berl) 96(8):791–806. https://doi.org/10.1007/s00109-018-1664-3

doi: 10.1007/s00109-018-1664-3 pubmed: 29955901

Davidson SM, Ferdinandy P, Andreadou I et al (2019) Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol 73(1):89–99. https://doi.org/10.1016/j.jacc.2018.09.086

doi: 10.1016/j.jacc.2018.09.086 pubmed: 30621955

Yang CF (2018) Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury. Ci Ji Yi Xue Za Zhi 30(4):209–215. https://doi.org/10.4103/tcmj.tcmj_33_18

doi: 10.4103/tcmj.tcmj_33_18 pubmed: 30305783

Wu E, Ortiz JT, Tejedor P et al (2008) Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94(6):730–736. https://doi.org/10.1136/hrt.2007.122622

doi: 10.1136/hrt.2007.122622 pubmed: 18070953

Majidi M, Kosinski AS, Al-Khatib SM et al (2009) Reperfusion ventricular arrhythmia “bursts” predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. Eur Heart J 30(7):757–764. https://doi.org/10.1093/eurheartj/ehp005

doi: 10.1093/eurheartj/ehp005 pubmed: 19202155

Saia F, Grigioni F, Marzocchi A et al (2010) Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction. Am Heart J 160(6 Suppl):S16-21. https://doi.org/10.1016/j.ahj.2010.10.011

doi: 10.1016/j.ahj.2010.10.011 pubmed: 21147287

Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(11):1121–1135. https://doi.org/10.1056/NEJMra071667

doi: 10.1056/NEJMra071667 pubmed: 17855673

Zou R, Shi W, Qiu J et al (2022) Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis. Cardiovasc Diabetol 21(1):106. https://doi.org/10.1186/s12933-022-01532-6

doi: 10.1186/s12933-022-01532-6 pubmed: 35705980 pmcid: 9202214

Wang J, Toan S, Zhou H (2020) New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis 23(3):299–314. https://doi.org/10.1007/s10456-020-09720-2

doi: 10.1007/s10456-020-09720-2 pubmed: 32246225

Wang J, Toan S, Zhou H (2020) Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: new insights into the mechanisms and therapeutic potentials. Pharmacol Res 156:104771. https://doi.org/10.1016/j.phrs.2020.104771

doi: 10.1016/j.phrs.2020.104771 pubmed: 32234339

Wu D, Ji H, Du W et al (2022) Mitophagy alleviates ischemia/reperfusion-induced microvascular damage through improving mitochondrial quality control. Bioengineered 13(2):3596–3607. https://doi.org/10.1080/21655979.2022.2027065

doi: 10.1080/21655979.2022.2027065 pubmed: 35112987 pmcid: 8973896

Chia PY, Teo A, Yeo TW (2020) Overview of the assessment of endothelial function in humans. Front Med (Lausanne) 7:542567. https://doi.org/10.3389/fmed.2020.542567

doi: 10.3389/fmed.2020.542567 pubmed: 33117828

Kloka JA, Friedrichson B, Wulfroth P et al (2023) Microvascular leakage as therapeutic target for ischemia and reperfusion injury. Cells. https://doi.org/10.3390/cells12101345

doi: 10.3390/cells12101345 pubmed: 37408180 pmcid: 10216082

Pinto AR, Ilinykh A, Ivey MJ et al (2016) Revisiting cardiac cellular composition. Circ Res 118(3):400–409. https://doi.org/10.1161/CIRCRESAHA.115.307778

doi: 10.1161/CIRCRESAHA.115.307778 pubmed: 26635390

Bassenge E, Heusch G (1990) Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 116:77–165. https://doi.org/10.1007/3540528806_4

doi: 10.1007/3540528806_4 pubmed: 2293307

Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed) 70(12):1082. https://doi.org/10.1016/j.rec.2017.11.010

doi: 10.1016/j.rec.2017.11.010 pubmed: 29198432

Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177. https://doi.org/10.1093/eurheartj/ehx393

doi: 10.1093/eurheartj/ehx393 pubmed: 28886621

Annibali G, Scrocca I, Aranzulla TC et al (2022) “No-Reflow” phenomenon: a contemporary review. J Clin Med. https://doi.org/10.3390/jcm11082233

doi: 10.3390/jcm11082233 pubmed: 36294319 pmcid: 9604741

Cai C, Guo Z, Chang X et al (2022) Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKalpha1/ULK1/FUNDC1/mitophagy pathway. Redox Biol 52:102288. https://doi.org/10.1016/j.redox.2022.102288

doi: 10.1016/j.redox.2022.102288 pubmed: 35325804 pmcid: 8938627

Heusch G, Kleinbongard P, Bose D et al (2009) Coronary microembolization: from bedside to bench and back to bedside. Circulation 120(18):1822–1836. https://doi.org/10.1161/CIRCULATIONAHA.109.888784

doi: 10.1161/CIRCULATIONAHA.109.888784 pubmed: 19884481

Alidoosti M, Lotfi R, Lotfi-Tokaldany M et al (2018) Correlates of the "No-Reflow" or "Slow-Flow" phenomenon in patients undergoing primary percutaneous coronary intervention. J Tehran Heart Cent, 13(3), 108–114. https://www.ncbi.nlm.nih.gov/pubmed/30745923 . Accessed 15 Aug 2023

Ambrosio G, Weisman HF, Mannisi JA et al (1989) Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80(6):1846–1861. https://doi.org/10.1161/01.cir.80.6.1846

doi: 10.1161/01.cir.80.6.1846 pubmed: 2598442

Reffelmann T, Kloner RA (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283(3):H1099-1107. https://doi.org/10.1152/ajpheart.00270.2002

doi: 10.1152/ajpheart.00270.2002 pubmed: 12181140

Harrison RW, Aggarwal A, Ou FS et al (2013) Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 111(2):178–184. https://doi.org/10.1016/j.amjcard.2012.09.015

doi: 10.1016/j.amjcard.2012.09.015 pubmed: 23111142

Schwartz BG, Kloner RA (2012) Coronary no reflow. J Mol Cell Cardiol 52(4):873–882. https://doi.org/10.1016/j.yjmcc.2011.06.009

doi: 10.1016/j.yjmcc.2011.06.009 pubmed: 21712046

Ndrepepa G, Tiroch K, Fusaro M et al (2010) 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55(21):2383–2389. https://doi.org/10.1016/j.jacc.2009.12.054

doi: 10.1016/j.jacc.2009.12.054 pubmed: 20488311

Niccoli G, Montone RA, Ibanez B et al (2019) Optimized treatment of ST-elevation myocardial infarction. Circ Res 125(2):245–258. https://doi.org/10.1161/CIRCRESAHA.119.315344

doi: 10.1161/CIRCRESAHA.119.315344 pubmed: 31268854

van Kranenburg M, Magro M, Thiele H et al (2014) Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 7(9):930–939. https://doi.org/10.1016/j.jcmg.2014.05.010

doi: 10.1016/j.jcmg.2014.05.010 pubmed: 25212799

Aggarwal P, Rekwal L, Sinha SK et al (2021) Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction. Ann Cardiol Angeiol (Paris) 70(3):136–142. https://doi.org/10.1016/j.ancard.2021.04.004

doi: 10.1016/j.ancard.2021.04.004 pubmed: 33962782

Ramadan R, Vromans E, Anang DC et al (2020) Connexin43 hemichannel targeting with TAT-Gap19 alleviates radiation-induced endothelial cell damage. Front Pharmacol 11:212. https://doi.org/10.3389/fphar.2020.00212

doi: 10.3389/fphar.2020.00212 pubmed: 32210810 pmcid: 7066501

Wang L, Ge C, Zhang X (2022) Sufentanil ameliorates oxygen-glucose deprivation/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K/Akt signaling pathway. Exp Ther Med 24(1):437. https://doi.org/10.3892/etm.2022.11364

doi: 10.3892/etm.2022.11364 pubmed: 35720630 pmcid: 9185804

Gao XM, Wu QZ, Kiriazis H et al (2017) Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging. Am J Physiol Heart Circ Physiol 312(5):H1068–H1075. https://doi.org/10.1152/ajpheart.00073.2017

doi: 10.1152/ajpheart.00073.2017 pubmed: 28341632

Kloner RA, Ganote CE, Jennings RB (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54(6):1496–1508. https://doi.org/10.1172/JCI107898

doi: 10.1172/JCI107898 pubmed: 4140198 pmcid: 301706

Heusch G (2019) Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol 114(6):45. https://doi.org/10.1007/s00395-019-0756-8

doi: 10.1007/s00395-019-0756-8 pubmed: 31617010

Kang S, Yang Y (2007) Coronary microvascular reperfusion injury and no-reflow in acute myocardial infarction. Clin Invest Med 30(3):E133-145. https://doi.org/10.25011/cim.v30i3.1082

doi: 10.25011/cim.v30i3.1082 pubmed: 17716552

Erkol A, Oduncu V, Turan B et al (2014) The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction. J Thromb Thrombolysis 38(3):339–347. https://doi.org/10.1007/s11239-013-1044-3

doi: 10.1007/s11239-013-1044-3 pubmed: 24407374

Grygier M, Araszkiewicz A, Lesiak M et al (2014) Intracoronary adenosine administered during aortocoronary vein graft interventions may reduce the incidence of no-reflow phenomenon. A pilot randomised trial. Kardiol Pol 72(2):126–133. https://doi.org/10.5603/KP.a2013.0213

doi: 10.5603/KP.a2013.0213 pubmed: 23990233

Li J, Wu L, Tian X et al (2015) Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction. PLoS ONE 10(6):e0119223. https://doi.org/10.1371/journal.pone.0119223

doi: 10.1371/journal.pone.0119223 pubmed: 26035818 pmcid: 4452793

Cenko E, Ricci B, Kedev S et al (2016) The no-reflow phenomenon in the young and in the elderly. Int J Cardiol 222:1122–1128. https://doi.org/10.1016/j.ijcard.2016.07.209

doi: 10.1016/j.ijcard.2016.07.209 pubmed: 27499222

Chen WR, Tian F, Chen YD et al (2016) Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction. Int J Cardiol 208:109–114. https://doi.org/10.1016/j.ijcard.2015.12.009

doi: 10.1016/j.ijcard.2015.12.009 pubmed: 26849684

Durante A, Laricchia A, Benedetti G et al (2017) Identification of high-risk patients after ST-segment-elevation myocardial infarction: comparison between angiographic and magnetic resonance parameters. Circ Cardiovasc Imaging 10(6):e005841. https://doi.org/10.1161/CIRCIMAGING.116.005841

doi: 10.1161/CIRCIMAGING.116.005841 pubmed: 28592591

Liang T, Liu M, Wu C et al (2017) Risk factors for no-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Invest Clin 69(3):139–145. https://doi.org/10.24875/ric.17002190

doi: 10.24875/ric.17002190 pubmed: 28613283

Li H, Fu DG, Liu FY et al (2018) Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI. Exp Ther Med 15(4):3940–3946. https://doi.org/10.3892/etm.2018.5900

doi: 10.3892/etm.2018.5900 pubmed: 29563988 pmcid: 5858114

Mahmoud AH, Taha NM, Baraka K et al (2019) Clinical and procedural predictors of suboptimal myocardial reperfusion in primary percutaneous coronary intervention. Int J Cardiol Heart Vasc 23:100357. https://doi.org/10.1016/j.ijcha.2019.100357

doi: 10.1016/j.ijcha.2019.100357 pubmed: 31032395 pmcid: 6477166

Yang L, Cong H, Lu Y et al (2020) Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Medicine (Baltimore) 99(26):e20152. https://doi.org/10.1097/MD.0000000000020152

doi: 10.1097/MD.0000000000020152 pubmed: 32590726

Rossington JA, Sol E, Masoura K et al (2020) No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case-control study (NORM PPCI). Open Heart. https://doi.org/10.1136/openhrt-2019-001215

doi: 10.1136/openhrt-2019-001215 pubmed: 32989014 pmcid: 7523192

Sadeghian M, Mousavi SH, Aamaraee Z et al (2022) Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction. Scand Cardiovasc J 56(1):23–27. https://doi.org/10.1080/14017431.2022.2035807

doi: 10.1080/14017431.2022.2035807 pubmed: 35253571

d’Entremont MA, Alazzoni A, Dzavik V et al (2023) No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention 19(5):e394–e401. https://doi.org/10.4244/EIJ-D-23-00112

doi: 10.4244/EIJ-D-23-00112 pubmed: 37382909

Eitel I, Wohrle J, Suenkel H et al (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61(13):1447–1454. https://doi.org/10.1016/j.jacc.2013.01.048

doi: 10.1016/j.jacc.2013.01.048 pubmed: 23466078

Hadamitzky M, Langhans B, Hausleiter J et al (2014) Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi. Eur Heart J Cardiovasc Imaging 15(2):216–225. https://doi.org/10.1093/ehjci/jet176

doi: 10.1093/ehjci/jet176 pubmed: 24243144

Kandler D, Lucke C, Grothoff M et al (2014) The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur Radiol 24(12):3277–3288. https://doi.org/10.1007/s00330-014-3318-3

doi: 10.1007/s00330-014-3318-3 pubmed: 25097126 pmcid: 4231283

Ding S, Li Z, Ge H et al (2015) Impact of early ST-segment changes on cardiac magnetic resonance-verified intramyocardial haemorrhage and microvascular obstruction in ST-elevation myocardial infarction patients. Medicine (Baltimore) 94(35):e1438. https://doi.org/10.1097/MD.0000000000001438

doi: 10.1097/MD.0000000000001438 pubmed: 26334905

Kim EK, Hahn JY, Song YB et al (2015) Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial. Int J Cardiovasc Imaging 31(3):629–637. https://doi.org/10.1007/s10554-015-0589-y

doi: 10.1007/s10554-015-0589-y pubmed: 25589306

Desch S, Stiermaier T, de Waha S et al (2016) Thrombus aspiration in patients with ST-segment elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc Interv 9(2):113–122. https://doi.org/10.1016/j.jcin.2015.09.010

doi: 10.1016/j.jcin.2015.09.010 pubmed: 26793952

Carrick D, Haig C, Ahmed N et al (2016) Myocardial Hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging 9(1):e004148. https://doi.org/10.1161/CIRCIMAGING.115.004148

doi: 10.1161/CIRCIMAGING.115.004148 pubmed: 26763281 pmcid: 4718183

Nazir SA, McCann GP, Greenwood JP et al (2016) Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J 37(24):1910–1919. https://doi.org/10.1093/eurheartj/ehw136

doi: 10.1093/eurheartj/ehw136 pubmed: 27147610 pmcid: 4917746

Kloner RA (2017) The importance of no-reflow/microvascular obstruction in the STEMI patient. Eur Heart J 38(47):3511–3513. https://doi.org/10.1093/eurheartj/ehx288

doi: 10.1093/eurheartj/ehx288 pubmed: 29020371

Broch K, Anstensrud AK, Woxholt S et al (2021) Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 77(15):1845–1855. https://doi.org/10.1016/j.jacc.2021.02.049

doi: 10.1016/j.jacc.2021.02.049 pubmed: 33858620

Bulluck H, Carberry J, Carrick D et al (2022) A noncontrast CMR risk score for long-term risk stratification in reperfused ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 15(3):431–440. https://doi.org/10.1016/j.jcmg.2021.08.006

doi: 10.1016/j.jcmg.2021.08.006 pubmed: 35272808

Tiller C, Reindl M, Holzknecht M et al (2022) Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 11(2):113–123. https://doi.org/10.1093/ehjacc/zuab110

doi: 10.1093/ehjacc/zuab110 pubmed: 34849677

Li Z, Yin H, Wang D et al (2022) Prediction of microvascular obstruction by coronary artery angiography score after acute ST-segment elevation myocardial infarction: a single-center retrospective observational study. BMC Cardiovasc Disord 22(1):410. https://doi.org/10.1186/s12872-022-02836-x

doi: 10.1186/s12872-022-02836-x pubmed: 36104684 pmcid: 9472358

Husser O, Monmeneu JV, Sanchis J et al (2013) Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Int J Cardiol 167(5):2047–2054. https://doi.org/10.1016/j.ijcard.2012.05.055

doi: 10.1016/j.ijcard.2012.05.055 pubmed: 22682700

Carrick D, Haig C, Ahmed N et al (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications. J Am Heart Assoc. https://doi.org/10.1161/JAHA.115.002834

doi: 10.1161/JAHA.115.002834 pubmed: 26908408 pmcid: 4802451

Garg P, Broadbent DA, Swoboda PP et al (2017) Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction. J Cardiovasc Magn Reson 19(1):73. https://doi.org/10.1186/s12968-017-0384-0

doi: 10.1186/s12968-017-0384-0 pubmed: 28946878 pmcid: 5613621

Homme RP, George AK, Singh M et al (2021) Mechanism of blood-heart-barrier leakage: implications for COVID-19 induced cardiovascular injury. Int J Mol Sci. https://doi.org/10.3390/ijms222413546

doi: 10.3390/ijms222413546 pubmed: 34948342 pmcid: 8706694

Li S, Chen J, Liu M et al (2021) Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia-reperfusion injury. Basic Res Cardiol 116(1):65. https://doi.org/10.1007/s00395-021-00905-4

doi: 10.1007/s00395-021-00905-4 pubmed: 34914018 pmcid: 8677646

Tian F, Zhang Y (2021) Overexpression of SERCA2a alleviates cardiac microvascular ischemic injury by suppressing Mfn2-mediated ER/mitochondrial calcium tethering. Front Cell Dev Biol 9:636553. https://doi.org/10.3389/fcell.2021.636553

doi: 10.3389/fcell.2021.636553 pubmed: 33869181 pmcid: 8047138

Fernandez-Jimenez R, Garcia-Prieto J, Sanchez-Gonzalez J et al (2015) Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol 66(7):816–828. https://doi.org/10.1016/j.jacc.2015.06.023

doi: 10.1016/j.jacc.2015.06.023 pubmed: 26271065

Kar S, Kavdia M (2011) Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production. Free Radic Biol Med 51(7):1411–1427. https://doi.org/10.1016/j.freeradbiomed.2011.06.009

doi: 10.1016/j.freeradbiomed.2011.06.009 pubmed: 21742028 pmcid: 3184605

Jones SA, O’Donnell VB, Wood JD et al (1996) Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271(4 Pt 2):H1626-1634. https://doi.org/10.1152/ajpheart.1996.271.4.H1626

doi: 10.1152/ajpheart.1996.271.4.H1626 pubmed: 8897960

Schroder K, Zhang M, Benkhoff S et al (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110(9):1217–1225. https://doi.org/10.1161/CIRCRESAHA.112.267054

doi: 10.1161/CIRCRESAHA.112.267054 pubmed: 22456182

Herring N, Tapoulal N, Kalla M et al (2019) Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Eur Heart J 40(24):1920–1929. https://doi.org/10.1093/eurheartj/ehz115

doi: 10.1093/eurheartj/ehz115 pubmed: 30859228 pmcid: 6588241

Alex L, Frangogiannis NG (2019) Pericytes in the infarcted heart. Vasc Biol 1(1):H23–H31. https://doi.org/10.1530/VB-19-0007

doi: 10.1530/VB-19-0007 pubmed: 32923950 pmcid: 7439839

Simonavicius N, Ashenden M, van Weverwijk A et al (2012) Pericytes promote selective vessel regression to regulate vascular patterning. Blood 120(7):1516–1527. https://doi.org/10.1182/blood-2011-01-332338

doi: 10.1182/blood-2011-01-332338 pubmed: 22740442

O’Farrell FM, Mastitskaya S, Hammond-Haley M et al (2017) Capillary pericytes mediate coronary no-reflow after myocardial ischaemia. Elife. https://doi.org/10.7554/eLife.29280

doi: 10.7554/eLife.29280 pubmed: 29120327 pmcid: 5705208

Shi Y, Hu G, Su J et al (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 20(5):510–518. https://doi.org/10.1038/cr.2010.44

doi: 10.1038/cr.2010.44 pubmed: 20368733

Stark K, Eckart A, Haidari S et al (2013) Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and “instruct” them with pattern-recognition and motility programs. Nat Immunol 14(1):41–51. https://doi.org/10.1038/ni.2477

doi: 10.1038/ni.2477 pubmed: 23179077

Deckelbaum RA, Lobov IB, Cheung E et al (2020) The potassium channel Kcne3 is a VEGFA-inducible gene selectively expressed by vascular endothelial tip cells. Angiogenesis 23(2):179–192. https://doi.org/10.1007/s10456-019-09696-8

doi: 10.1007/s10456-019-09696-8 pubmed: 31754927

Bazzoni G, Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84(3):869–901. https://doi.org/10.1152/physrev.00035.2003

doi: 10.1152/physrev.00035.2003 pubmed: 15269339

Pohl U (2020) Connexins: key players in the control of vascular plasticity and function. Physiol Rev 100(2):525–572. https://doi.org/10.1152/physrev.00010.2019

doi: 10.1152/physrev.00010.2019 pubmed: 31939708

Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41–53. https://doi.org/10.1038/nrn1824

doi: 10.1038/nrn1824 pubmed: 16371949

Strauss RE, Gourdie RG (2020) Cx43 and the actin cytoskeleton: novel roles and implications for cell-cell junction-based barrier function regulation. Biomolecules. https://doi.org/10.3390/biom10121656

doi: 10.3390/biom10121656 pubmed: 33321985 pmcid: 7764618

Yuan SY, Wu MH, Ustinova EE et al (2002) Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 90(11):1214–1221. https://doi.org/10.1161/01.res.0000020402.73609.f1

doi: 10.1161/01.res.0000020402.73609.f1 pubmed: 12065325

Shen Q, Rigor RR, Pivetti CD et al (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 87(2):272–280. https://doi.org/10.1093/cvr/cvq144

doi: 10.1093/cvr/cvq144 pubmed: 20479130 pmcid: 2895546

Huang H, He J, Johnson D et al (2015) Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1alpha-VEGF pathway inhibition. Diabetes 64(1):200–212. https://doi.org/10.2337/db14-0016

doi: 10.2337/db14-0016 pubmed: 25187372

Antonetti DA, Barber AJ, Hollinger LA et al (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274(33):23463–23467. https://doi.org/10.1074/jbc.274.33.23463

doi: 10.1074/jbc.274.33.23463 pubmed: 10438525

Wang W, Lo ACY (2018) Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. https://doi.org/10.3390/ijms19061816

doi: 10.3390/ijms19061816 pubmed: 30597963 pmcid: 6337580

Hilbert T, Klaschik S (2015) The angiopoietin/TIE receptor system: focusing its role for ischemia-reperfusion injury. Cytokine Growth Factor Rev 26(3):281–291. https://doi.org/10.1016/j.cytogfr.2014.10.013

doi: 10.1016/j.cytogfr.2014.10.013 pubmed: 25466648

Zhang Y, Kontos CD, Annex BH et al (2019) Angiopoietin-tie signaling pathway in endothelial cells: a computational model. iScience 20:497–511. https://doi.org/10.1016/j.isci.2019.10.006

doi: 10.1016/j.isci.2019.10.006 pubmed: 31655061 pmcid: 6806670

Patel JV, Lim HS, Varughese GI et al (2008) Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann Med 40(3):215–222. https://doi.org/10.1080/07853890701779586

doi: 10.1080/07853890701779586 pubmed: 18382887

Rangasamy S, Srinivasan R, Maestas J et al (2011) A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci 52(6):3784–3791. https://doi.org/10.1167/iovs.10-6386

doi: 10.1167/iovs.10-6386 pubmed: 21310918 pmcid: 3109054

Raza Z, Saleem U, Naureen Z (2020) Sphingosine 1-phosphate signaling in ischemia and reperfusion injury. Prostaglandins Other Lipid Mediat 149:106436. https://doi.org/10.1016/j.prostaglandins.2020.106436

doi: 10.1016/j.prostaglandins.2020.106436 pubmed: 32173486

Wilkerson BA (2014) The role of sphingosine-1-phosphate in endothelial barrier function. Biochim Biophys Acta 1841(10):1403–1412. https://doi.org/10.1016/j.bbalip.2014.06.012

doi: 10.1016/j.bbalip.2014.06.012 pubmed: 25009123 pmcid: 4169319

Morel S, Christoffersen C, Axelsen LN et al (2016) Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. Cardiovasc Res 109(3):385–396. https://doi.org/10.1093/cvr/cvw004

doi: 10.1093/cvr/cvw004 pubmed: 26762268 pmcid: 4752044

Alarcon-Martinez L, Villafranca-Baughman D, Quintero H et al (2020) Interpericyte tunnelling nanotubes regulate neurovascular coupling. Nature 585(7823):91–95. https://doi.org/10.1038/s41586-020-2589-x

doi: 10.1038/s41586-020-2589-x pubmed: 32788726

Rodrigues SF, Granger DN (2010) Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. Cardiovasc Res 87(2):291–299. https://doi.org/10.1093/cvr/cvq090

doi: 10.1093/cvr/cvq090 pubmed: 20299333 pmcid: 2895540

Dorge H, Neumann T, Behrends M et al (2000) Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 279(6):H2587-2592. https://doi.org/10.1152/ajpheart.2000.279.6.H2587

doi: 10.1152/ajpheart.2000.279.6.H2587 pubmed: 11087208

Giordano G, Napolitano M, Cellurale M et al (2022) Circulating endothelial cell levels correlate with treatment outcomes of splanchnic vein thrombosis in patients with chronic myeloproliferative neoplasms. J Pers Med. https://doi.org/10.3390/jpm12030364

doi: 10.3390/jpm12030364 pubmed: 36556290 pmcid: 9781311

Damani S, Bacconi A, Libiger O et al (2012) Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 4(126):126ea133. https://doi.org/10.1126/scitranslmed.3003451

doi: 10.1126/scitranslmed.3003451

Chen CW, Wang LL, Zaman S et al (2018) Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction. Cardiovasc Res 114(7):1029–1040. https://doi.org/10.1093/cvr/cvy067

doi: 10.1093/cvr/cvy067 pubmed: 29566124 pmcid: 5967544

Ridger VC, Boulanger CM, Angelillo-Scherrer A et al (2017) Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. Thromb Haemost 117(7):1296–1316. https://doi.org/10.1160/TH16-12-0943

doi: 10.1160/TH16-12-0943 pubmed: 28569921

Zhang J, Zhu Y, Wu Y et al (2020) Synergistic effects of EMPs and PMPs on pulmonary vascular leakage and lung injury after ischemia/reperfusion. Cell Commun Signal 18(1):184. https://doi.org/10.1186/s12964-020-00672-0

doi: 10.1186/s12964-020-00672-0 pubmed: 33225929 pmcid: 7682096

Li F, Liu D, Liu M et al (2022) Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice. J Nanobiotechnology 20(1):251. https://doi.org/10.1186/s12951-022-01445-2

doi: 10.1186/s12951-022-01445-2 pubmed: 35659239 pmcid: 9164893

Kloner RA, Giacomelli F, Alker KJ et al (1991) Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 84(4):1758–1772. https://doi.org/10.1161/01.cir.84.4.1758

doi: 10.1161/01.cir.84.4.1758 pubmed: 1914113

Ge L, Zhou X, Ji WJ et al (2015) Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am J Physiol Heart Circ Physiol 308(5):H500-509. https://doi.org/10.1152/ajpheart.00381.2014

doi: 10.1152/ajpheart.00381.2014 pubmed: 25527775

Coenen DM, Mastenbroek TG, Cosemans J (2017) Platelet interaction with activated endothelium: mechanistic insights from microfluidics. Blood 130(26):2819–2828. https://doi.org/10.1182/blood-2017-04-780825

doi: 10.1182/blood-2017-04-780825 pubmed: 29018081

Schanze N, Bode C, Duerschmied D (2019) Platelet contributions to myocardial ischemia/reperfusion injury. Front Immunol 10:1260. https://doi.org/10.3389/fimmu.2019.01260

doi: 10.3389/fimmu.2019.01260 pubmed: 31244834 pmcid: 6562336

Konijnenberg LSF, Damman P, Duncker DJ et al (2020) Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res 116(4):787–805. https://doi.org/10.1093/cvr/cvz301

doi: 10.1093/cvr/cvz301 pubmed: 31710673

Rasola A, Bernardi P (2011) Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 50(3):222–233. https://doi.org/10.1016/j.ceca.2011.04.007

doi: 10.1016/j.ceca.2011.04.007 pubmed: 21601280

Orrenius S, Gogvadze V, Zhivotovsky B (2015) Calcium and mitochondria in the regulation of cell death. Biochem Biophys Res Commun 460(1):72–81. https://doi.org/10.1016/j.bbrc.2015.01.137

doi: 10.1016/j.bbrc.2015.01.137 pubmed: 25998735

Li C, Ma Q, Toan S et al (2020) SERCA overexpression reduces reperfusion-mediated cardiac microvascular damage through inhibition of the calcium/MCU/mPTP/necroptosis signaling pathways. Redox Biol 36:101659. https://doi.org/10.1016/j.redox.2020.101659

doi: 10.1016/j.redox.2020.101659 pubmed: 32738788 pmcid: 7395441

Alevriadou BR, Patel A, Noble M et al (2021) Molecular nature and physiological role of the mitochondrial calcium uniporter channel. Am J Physiol Cell Physiol 320(4):C465–C482. https://doi.org/10.1152/ajpcell.00502.2020

doi: 10.1152/ajpcell.00502.2020 pubmed: 33296287

Tanwar J, Singh JB, Motiani RK (2021) Molecular machinery regulating mitochondrial calcium levels: the nuts and bolts of mitochondrial calcium dynamics. Mitochondrion 57:9–22. https://doi.org/10.1016/j.mito.2020.12.001

doi: 10.1016/j.mito.2020.12.001 pubmed: 33316420

Raffaello A, De Stefani D, Sabbadin D et al (2013) The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit. EMBO J 32(17):2362–2376. https://doi.org/10.1038/emboj.2013.157

doi: 10.1038/emboj.2013.157 pubmed: 23900286 pmcid: 3771344

Wu L, Tan JL, Chen ZY et al (2019) Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening. Basic Res Cardiol 114(5):39. https://doi.org/10.1007/s00395-019-0747-9

doi: 10.1007/s00395-019-0747-9 pubmed: 31463567

Gambardella J, Trimarco B, Iaccarino G et al (2018) New insights in cardiac calcium handling and excitation-contraction coupling. Adv Exp Med Biol 1067:373–385. https://doi.org/10.1007/5584_2017_106

doi: 10.1007/5584_2017_106 pubmed: 28956314 pmcid: 5889357

Gwathmey JK, Yerevanian AI, Hajjar RJ (2011) Cardiac gene therapy with SERCA2a: from bench to bedside. J Mol Cell Cardiol 50(5):803–812. https://doi.org/10.1016/j.yjmcc.2010.11.011

doi: 10.1016/j.yjmcc.2010.11.011 pubmed: 21093451

Periasamy M, Kalyanasundaram A (2007) SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 35(4):430–442. https://doi.org/10.1002/mus.20745

doi: 10.1002/mus.20745 pubmed: 17286271

Chen L, Sun Q, Zhou D et al (2017) HINT2 triggers mitochondrial Ca(2+) influx by regulating the mitochondrial Ca(2+) uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer. Cancer Lett 411:106–116. https://doi.org/10.1016/j.canlet.2017.09.020

doi: 10.1016/j.canlet.2017.09.020 pubmed: 28947137

Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334(6059):1081–1086. https://doi.org/10.1126/science.1209038

doi: 10.1126/science.1209038 pubmed: 22116877

Nie X, Tang W, Zhang Z et al (2020) Procyanidin B2 mitigates endothelial endoplasmic reticulum stress through a PPARdelta-Dependent mechanism. Redox Biol 37:101728. https://doi.org/10.1016/j.redox.2020.101728

doi: 10.1016/j.redox.2020.101728 pubmed: 32961442 pmcid: 7509074

Battson ML, Lee DM, Gentile CL (2017) Endoplasmic reticulum stress and the development of endothelial dysfunction. Am J Physiol Heart Circ Physiol 312(3):H355–H367. https://doi.org/10.1152/ajpheart.00437.2016

doi: 10.1152/ajpheart.00437.2016 pubmed: 27923788

Cao SS, Kaufman RJ (2014) Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 21(3):396–413. https://doi.org/10.1089/ars.2014.5851

doi: 10.1089/ars.2014.5851 pubmed: 24702237 pmcid: 4076992

Rizzuto R, De Stefani D, Raffaello A et al (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13(9):566–578. https://doi.org/10.1038/nrm3412

doi: 10.1038/nrm3412 pubmed: 22850819

Rainbolt TK, Saunders JM, Wiseman RL (2014) Stress-responsive regulation of mitochondria through the ER unfolded protein response. Trends Endocrinol Metab 25(10):528–537. https://doi.org/10.1016/j.tem.2014.06.007

doi: 10.1016/j.tem.2014.06.007 pubmed: 25048297

He X, Bi XY, Lu XZ et al (2015) Reduction of mitochondria-endoplasmic reticulum interactions by acetylcholine protects human umbilical vein endothelial cells from hypoxia/reoxygenation injury. Arterioscler Thromb Vasc Biol 35(7):1623–1634. https://doi.org/10.1161/ATVBAHA.115.305469

doi: 10.1161/ATVBAHA.115.305469 pubmed: 25977565

Kirkman DL, Robinson AT, Rossman MJ et al (2021) Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases. Am J Physiol Heart Circ Physiol 320(5):H2080–H2100. https://doi.org/10.1152/ajpheart.00917.2020

doi: 10.1152/ajpheart.00917.2020 pubmed: 33834868 pmcid: 8163660

Daiber A, Andreadou I, Oelze M et al (2021) Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure. Free Radic Biol Med 163:325–343. https://doi.org/10.1016/j.freeradbiomed.2020.12.026

doi: 10.1016/j.freeradbiomed.2020.12.026 pubmed: 33359685

Jiang X, Wu D, Jiang Z et al (2021) Protective effect of nicorandil on cardiac microvascular injury: role of mitochondrial integrity. Oxid Med Cell Longev 2021:4665632. https://doi.org/10.1155/2021/4665632

doi: 10.1155/2021/4665632 pubmed: 34285763 pmcid: 8275446

Maier-Begandt D, Comstra HS, Molina SA et al (2021) A venous-specific purinergic signaling cascade initiated by Pannexin 1 regulates TNFalpha-induced increases in endothelial permeability. Sci Signal. https://doi.org/10.1126/scisignal.aba2940

doi: 10.1126/scisignal.aba2940 pubmed: 33653920 pmcid: 8011850

Zhou H, Hu S, Jin Q et al (2017) Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP opening. J Am Heart Assoc. https://doi.org/10.1161/JAHA.116.005328

doi: 10.1161/JAHA.116.005328 pubmed: 29051216 pmcid: 5721870

Kalia R, Wang RY, Yusuf A et al (2018) Structural basis of mitochondrial receptor binding and constriction by DRP1. Nature 558(7710):401–405. https://doi.org/10.1038/s41586-018-0211-2

doi: 10.1038/s41586-018-0211-2 pubmed: 29899447 pmcid: 6120343

Kraus F, Roy K, Pucadyil TJ et al (2021) Function and regulation of the divisome for mitochondrial fission. Nature 590(7844):57–66. https://doi.org/10.1038/s41586-021-03214-x

doi: 10.1038/s41586-021-03214-x pubmed: 33536648

Yu Y, Peng XD, Qian XJ et al (2021) Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis. Signal Transduct Target Ther 6(1):401. https://doi.org/10.1038/s41392-021-00790-2

doi: 10.1038/s41392-021-00790-2 pubmed: 34848680 pmcid: 8632923

Chen Y, Li S, Zhang Y et al (2021) The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biol 41:101910. https://doi.org/10.1016/j.redox.2021.101910

doi: 10.1016/j.redox.2021.101910 pubmed: 33667993 pmcid: 7937833

Depoix CL, Colson A, Hubinont C et al (2020) Impaired vascular endothelial growth factor expression and secretion during in vitro differentiation of human primary term cytotrophoblasts. Angiogenesis 23(2):221–230. https://doi.org/10.1007/s10456-019-09702-z

doi: 10.1007/s10456-019-09702-z pubmed: 31894427

Damico R, Zulueta JJ, Hassoun PM (2012) Pulmonary endothelial cell NOX. Am J Respir Cell Mol Biol 47(2):129–139. https://doi.org/10.1165/rcmb.2010-0331RT

doi: 10.1165/rcmb.2010-0331RT pubmed: 22499852 pmcid: 5460906

Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 105(2):151–154. https://doi.org/10.1007/s00395-009-0080-9

doi: 10.1007/s00395-009-0080-9 pubmed: 20066536

Zhou H, Shi C, Hu S et al (2018) BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathways. Angiogenesis 21(3):599–615. https://doi.org/10.1007/s10456-018-9611-z

doi: 10.1007/s10456-018-9611-z pubmed: 29623489

Zhou H, Wang J, Zhu P et al (2018) Ripk3 regulates cardiac microvascular reperfusion injury: The role of IP3R-dependent calcium overload, XO-mediated oxidative stress and F-action/filopodia-based cellular migration. Cell Signal 45:12–22. https://doi.org/10.1016/j.cellsig.2018.01.020

doi: 10.1016/j.cellsig.2018.01.020 pubmed: 29413844

Zhou H, Wang J, Zhu P et al (2018) NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2alpha. Basic Res Cardiol 113(4):23. https://doi.org/10.1007/s00395-018-0682-1

doi: 10.1007/s00395-018-0682-1 pubmed: 29744594

Kwong JQ, Davis J, Baines CP et al (2014) Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21(8):1209–1217. https://doi.org/10.1038/cdd.2014.36

doi: 10.1038/cdd.2014.36 pubmed: 24658400 pmcid: 4085527

Zhu H, Toan S, Mui D et al (2021) Mitochondrial quality surveillance as a therapeutic target in myocardial infarction. Acta Physiol (Oxf) 231(3):e13590. https://doi.org/10.1111/apha.13590

doi: 10.1111/apha.13590 pubmed: 33270362

Zhou H, Ren J, Toan S et al (2021) Role of mitochondrial quality surveillance in myocardial infarction: From bench to bedside. Ageing Res Rev 66:101250. https://doi.org/10.1016/j.arr.2020.101250

doi: 10.1016/j.arr.2020.101250 pubmed: 33388396

Song Y, Xing H, He Y et al (2021) Inhibition of mitochondrial reactive oxygen species improves coronary endothelial function after cardioplegic hypoxia/reoxygenation. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.06.029

doi: 10.1016/j.jtcvs.2021.06.029 pubmed: 34531042 pmcid: 8710187

Chen Y, Liu C, Zhou P et al (2021) Coronary Endothelium No-Reflow Injury Is Associated with ROS-Modified Mitochondrial Fission through the JNK-Drp1 Signaling Pathway. Oxid Med Cell Longev 2021:6699516. https://doi.org/10.1155/2021/6699516

doi: 10.1155/2021/6699516 pubmed: 33613824 pmcid: 7878075

Ribeiro LF, Catarino T, Carvalho M et al (2021) Ligand-independent activity of the ghrelin receptor modulates AMPA receptor trafficking and supports memory formation. Sci Signal. https://doi.org/10.1126/scisignal.abb1953

doi: 10.1126/scisignal.abb1953 pubmed: 33593997

Skyschally A, Amanakis G, Neuhauser M et al (2017) Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning. Am J Physiol Heart Circ Physiol 313(5):H871–H878. https://doi.org/10.1152/ajpheart.00293.2017

doi: 10.1152/ajpheart.00293.2017 pubmed: 28778913

Chang X, Li Y, Cai C et al (2022) Mitochondrial quality control mechanisms as molecular targets in diabetic heart. Metabolism 137:155313. https://doi.org/10.1016/j.metabol.2022.155313

doi: 10.1016/j.metabol.2022.155313 pubmed: 36126721

Jin H, Zhu Y, Li Y et al (2019) BDNF-mediated mitophagy alleviates high-glucose-induced brain microvascular endothelial cell injury. Apoptosis 24(5–6):511–528. https://doi.org/10.1007/s10495-019-01535-x

doi: 10.1007/s10495-019-01535-x pubmed: 30877409

Zheng J, Lu C (2020) Oxidized LDL Causes Endothelial Apoptosis by Inhibiting Mitochondrial Fusion and Mitochondria Autophagy. Front Cell Dev Biol 8:600950. https://doi.org/10.3389/fcell.2020.600950

doi: 10.3389/fcell.2020.600950 pubmed: 33262989 pmcid: 7686653

Sun L, Hao Y, An R et al (2014) Overexpression of Rcan1–1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy. Mol Cells 37(11):785–794. https://doi.org/10.14348/molcells.2014.0103

doi: 10.14348/molcells.2014.0103 pubmed: 25377251 pmcid: 4255098

Zhou H, Zhang Y, Hu S et al (2017) Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res. https://doi.org/10.1111/jpi.12413

doi: 10.1111/jpi.12413 pubmed: 28981157 pmcid: 5518188

Bravo-San Pedro JM, Kroemer G, Galluzzi L (2017) Autophagy and mitophagy in cardiovascular disease. Circ Res 120(11):1812–1824. https://doi.org/10.1161/CIRCRESAHA.117.311082

doi: 10.1161/CIRCRESAHA.117.311082 pubmed: 28546358

Battistutta R, Lolli G (2011) Structural and functional determinants of protein kinase CK2alpha: facts and open questions. Mol Cell Biochem 356(1–2):67–73. https://doi.org/10.1007/s11010-011-0939-6

doi: 10.1007/s11010-011-0939-6 pubmed: 21739155

Chen G, Han Z, Feng D et al (2014) A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell 54(3):362–377. https://doi.org/10.1016/j.molcel.2014.02.034

doi: 10.1016/j.molcel.2014.02.034 pubmed: 24746696

Zhou H, Zhu P, Wang J et al (2018) Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2alpha-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy. Cell Death Differ 25(6):1080–1093. https://doi.org/10.1038/s41418-018-0086-7

doi: 10.1038/s41418-018-0086-7 pubmed: 29540794 pmcid: 5988750

Gao XM, Su Y, Moore S et al (2019) Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion. Basic Res Cardiol 114(4):30. https://doi.org/10.1007/s00395-019-0739-9

doi: 10.1007/s00395-019-0739-9 pubmed: 31218471

Gao XM, Wang BH, Woodcock E et al (2000) Expression of active alpha(1B)-adrenergic receptors in the heart does not alleviate ischemic reperfusion injury. J Mol Cell Cardiol 32(9):1679–1686. https://doi.org/10.1006/jmcc.2000.1201

doi: 10.1006/jmcc.2000.1201 pubmed: 10966830

Gao XM, Liu Y, White D et al (2011) Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 50(6):991–999. https://doi.org/10.1016/j.yjmcc.2010.12.022

doi: 10.1016/j.yjmcc.2010.12.022 pubmed: 21215754

Gao XM, Moore XL, Liu Y et al (2016) Splenic release of platelets contributes to increased circulating platelet size and inflammation after myocardial infarction. Clin Sci (Lond) 130(13):1089–1104. https://doi.org/10.1042/CS20160234

doi: 10.1042/CS20160234 pubmed: 27129192

McLaughlin MG, Stone GW, Aymong E et al (2004) Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44(6):1215–1223. https://doi.org/10.1016/j.jacc.2004.06.053

doi: 10.1016/j.jacc.2004.06.053 pubmed: 15364322

Karamasis GV, Russhard P, Al Janabi F et al (2018) Peri-procedural ST segment resolution during Primary Percutaneous Coronary Intervention (PPCI) for acute myocardial infarction: predictors and clinical consequences. J Electrocardiol 51(2):224–229. https://doi.org/10.1016/j.jelectrocard.2017.09.011

doi: 10.1016/j.jelectrocard.2017.09.011 pubmed: 29108788

Bethke A, Halvorsen S, Bohmer E et al (2015) Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty). EuroIntervention 11(5):518–524. https://doi.org/10.4244/EIJY15M04_02

doi: 10.4244/EIJY15M04_02 pubmed: 25868877

Roubille F, Mewton N, Elbaz M et al (2014) No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2–3 on admission. Eur Heart J 35(25):1675–1682. https://doi.org/10.1093/eurheartj/ehu054

doi: 10.1093/eurheartj/ehu054 pubmed: 24585265

Moroni F, Azzalini L, Caixeta A et al (2022) TIMI flow and myocardial blushing after rescue PCI and cardiac magnetic resonance: results from the Myocardial Salvage After Rescue Angioplasty: Evaluation by Magnetic Resonance (SAVE-ME) study. Int J Cardiol. https://doi.org/10.1016/j.ijcard.2022.08.014

doi: 10.1016/j.ijcard.2022.08.014 pubmed: 36455702 pmcid: 8915449

Ellis SG, Topol EJ, Gallison L et al (1988) Predictors of success for coronary angioplasty performed for acute myocardial infarction. J Am Coll Cardiol 12(6):1407–1415. https://doi.org/10.1016/s0735-1097(88)80003-2

doi: 10.1016/s0735-1097(88)80003-2 pubmed: 2973481

Ge H, Ding S, An D et al (2016) Frame counting improves the assessment of post-reperfusion microvascular patency by TIMI myocardial perfusion grade: evidence from cardiac magnetic resonance imaging. Int J Cardiol 203:360–366. https://doi.org/10.1016/j.ijcard.2015.10.194

doi: 10.1016/j.ijcard.2015.10.194 pubmed: 26539957

Bailleul C, Aissaoui N, Cayla G et al (2018) Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. Arch Cardiovasc Dis 111(2):101–108. https://doi.org/10.1016/j.acvd.2017.04.004

doi: 10.1016/j.acvd.2017.04.004 pubmed: 28939193

Joost A, Stiermaier T, Eitel C et al (2016) Impact of initial culprit vessel flow on infarct size, microvascular obstruction, and myocardial salvage in acute reperfused ST-elevation myocardial infarction. Am J Cardiol 118(9):1316–1322. https://doi.org/10.1016/j.amjcard.2016.07.056

doi: 10.1016/j.amjcard.2016.07.056 pubmed: 27600465

Gibson CM, Cannon CP, Daley WL et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5):879–888. https://doi.org/10.1161/01.cir.93.5.879

doi: 10.1161/01.cir.93.5.879 pubmed: 8598078

Jiang L, Yao H, Liang ZG (2017) Postoperative assessment of myocardial function and microcirculation in patients with acute coronary syndrome by myocardial contrast echocardiography. Med Sci Monit 23:2324–2332. https://doi.org/10.12659/msm.901233

doi: 10.12659/msm.901233 pubmed: 28514327 pmcid: 5443357

Verkaik M, van Poelgeest EM, Kwekkeboom RFJ et al (2018) Myocardial contrast echocardiography in mice: technical and physiological aspects. Am J Physiol Heart Circ Physiol 314(3):H381–H391. https://doi.org/10.1152/ajpheart.00242.2017

doi: 10.1152/ajpheart.00242.2017 pubmed: 29101165

Aggarwal S, Xie F, High R et al (2018) Prevalence and predictive value of microvascular flow abnormalities after successful contemporary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. J Am Soc Echocardiogr 31(6):674–682. https://doi.org/10.1016/j.echo.2018.01.009

doi: 10.1016/j.echo.2018.01.009 pubmed: 29525249

Greaves K, Dixon SR, Fejka M et al (2003) Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction. Heart 89(2):139–144. https://doi.org/10.1136/heart.89.2.139

doi: 10.1136/heart.89.2.139 pubmed: 12527661 pmcid: 1767552

Reinstadler SJ, Thiele H, Eitel I (2015) Risk stratification by cardiac magnetic resonance imaging after ST-elevation myocardial infarction. Curr Opin Cardiol 30(6):681–689. https://doi.org/10.1097/HCO.0000000000000227

doi: 10.1097/HCO.0000000000000227 pubmed: 26398412

Stiermaier T, Jobs A, de Waha S et al (2017) Optimized prognosis assessment in ST-segment-elevation myocardial infarction using a cardiac magnetic resonance imaging risk score. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.117.006774

doi: 10.1161/CIRCIMAGING.117.006774 pubmed: 29122844

Eitel I, de Waha S, Wohrle J et al (2014) Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(12):1217–1226. https://doi.org/10.1016/j.jacc.2014.06.1194

doi: 10.1016/j.jacc.2014.06.1194 pubmed: 25236513

Zhou D, Xu J, Zhao S et al (2020) CMR publications from China of the last more than 30 years. Int J Cardiovasc Imaging 36(9):1737–1747. https://doi.org/10.1007/s10554-020-01873-x

doi: 10.1007/s10554-020-01873-x pubmed: 32394180

Perazzolo Marra M, Lima JA, Iliceto S (2011) MRI in acute myocardial infarction. Eur Heart J 32(3):284–293. https://doi.org/10.1093/eurheartj/ehq409

doi: 10.1093/eurheartj/ehq409 pubmed: 21112897

Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542. https://doi.org/10.1161/hc0402.102975

doi: 10.1161/hc0402.102975 pubmed: 11815441

Higgins CB, Herfkens R, Lipton MJ et al (1983) Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 52(1):184–188. https://doi.org/10.1016/0002-9149(83)90093-0

doi: 10.1016/0002-9149(83)90093-0 pubmed: 6858909

Aletras AH, Tilak GS, Natanzon A et al (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113(15):1865–1870. https://doi.org/10.1161/CIRCULATIONAHA.105.576025

doi: 10.1161/CIRCULATIONAHA.105.576025 pubmed: 16606793

Simonetti OP, Finn JP, White RD et al (1996) “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 199(1):49–57. https://doi.org/10.1148/radiology.199.1.8633172

doi: 10.1148/radiology.199.1.8633172 pubmed: 8633172

Friedrich MG, Abdel-Aty H, Taylor A et al (2008) The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 51(16):1581–1587. https://doi.org/10.1016/j.jacc.2008.01.019

doi: 10.1016/j.jacc.2008.01.019 pubmed: 18420102

Reinstadler SJ, Stiermaier T, Fuernau G et al (2016) The challenges and impact of microvascular injury in ST-elevation myocardial infarction. Expert Rev Cardiovasc Ther 14(4):431–443. https://doi.org/10.1586/14779072.2016.1135055

doi: 10.1586/14779072.2016.1135055 pubmed: 26794717

Shin JM, Choi EY, Park CH et al (2020) Quantitative T1 mapping for detecting microvascular obstruction in reperfused acute myocardial infarction: comparison with late gadolinium enhancement imaging. Korean J Radiol 21(8):978–986. https://doi.org/10.3348/kjr.2019.0736

doi: 10.3348/kjr.2019.0736 pubmed: 32677382 pmcid: 7369203

Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218(1):215–223. https://doi.org/10.1148/radiology.218.1.r01ja50215

doi: 10.1148/radiology.218.1.r01ja50215 pubmed: 11152805

Dastidar AG, Harries I, Pontecorboli G et al (2019) Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique. Int J Cardiovasc Imaging 35(3):517–527. https://doi.org/10.1007/s10554-018-1467-1

doi: 10.1007/s10554-018-1467-1 pubmed: 30357547

Judd RM, Lugo-Olivieri CH, Arai M et al (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92(7):1902–1910. https://doi.org/10.1161/01.cir.92.7.1902

doi: 10.1161/01.cir.92.7.1902 pubmed: 7671375

Ibrahim T, Nekolla SG, Hornke M et al (2005) Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 45(4):544–552. https://doi.org/10.1016/j.jacc.2004.10.058

doi: 10.1016/j.jacc.2004.10.058 pubmed: 15708702

Kirschner R, Varga-Szemes A, Brott BC et al (2011) Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping. Magn Reson Imaging 29(5):650–658. https://doi.org/10.1016/j.mri.2011.02.010

doi: 10.1016/j.mri.2011.02.010 pubmed: 21546192 pmcid: 3131177

McAlindon E, Pufulete M, Lawton C et al (2015) Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications. Eur Heart J Cardiovasc Imaging 16(7):738–746. https://doi.org/10.1093/ehjci/jev001

doi: 10.1093/ehjci/jev001 pubmed: 25736308 pmcid: 4463003

Stone GW, Selker HP, Thiele H et al (2016) Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol 67(14):1674–1683. https://doi.org/10.1016/j.jacc.2016.01.069

doi: 10.1016/j.jacc.2016.01.069 pubmed: 27056772

Wu KC, Kim RJ, Bluemke DA et al (1998) Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 32(6):1756–1764. https://doi.org/10.1016/s0735-1097(98)00429-x

doi: 10.1016/s0735-1097(98)00429-x pubmed: 9822106

Bulluck H, Dharmakumar R, Arai AE et al (2018) Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation 137(18):1949–1964. https://doi.org/10.1161/CIRCULATIONAHA.117.030693

doi: 10.1161/CIRCULATIONAHA.117.030693 pubmed: 29712696 pmcid: 5933067

Lima JA, Judd RM, Bazille A et al (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92(5):1117–1125. https://doi.org/10.1161/01.cir.92.5.1117

doi: 10.1161/01.cir.92.5.1117 pubmed: 7648655

Hombach V, Grebe O, Merkle N et al (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26(6):549–557. https://doi.org/10.1093/eurheartj/ehi147

doi: 10.1093/eurheartj/ehi147 pubmed: 15713695

Garcia-Dorado D, Oliveras J, Gili J et al (1993) Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 27(8):1462–1469. https://doi.org/10.1093/cvr/27.8.1462

doi: 10.1093/cvr/27.8.1462 pubmed: 8297415

Boxt LM, Hsu D, Katz J et al (1993) Estimation of myocardial water content using transverse relaxation time from dual spin-echo magnetic resonance imaging. Magn Reson Imaging 11(3):375–383. https://doi.org/10.1016/0730-725x(93)90070-t

doi: 10.1016/0730-725x(93)90070-t pubmed: 8505871

Robbers LF, Eerenberg ES, Teunissen PF et al (2013) Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 34(30):2346–2353. https://doi.org/10.1093/eurheartj/eht100

doi: 10.1093/eurheartj/eht100 pubmed: 23594591

O’Regan DP, Ahmed R, Karunanithy N et al (2009) Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology 250(3):916–922. https://doi.org/10.1148/radiol.2503081154

doi: 10.1148/radiol.2503081154 pubmed: 19164125

Walsh SR, Tang TY, Kullar P et al (2008) Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg 34(5):985–994. https://doi.org/10.1016/j.ejcts.2008.07.062

doi: 10.1016/j.ejcts.2008.07.062 pubmed: 18783958

Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116(4):674–699. https://doi.org/10.1161/CIRCRESAHA.116.305348

doi: 10.1161/CIRCRESAHA.116.305348 pubmed: 25677517

Liu J, Gu Y, Guo M et al (2021) Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases. CNS Neurosci Ther 27(8):869–882. https://doi.org/10.1111/cns.13642

doi: 10.1111/cns.13642 pubmed: 34237192 pmcid: 8265941

Wever KE, Menting TP, Rovers M et al (2012) Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS ONE 7(2):e32296. https://doi.org/10.1371/journal.pone.0032296

doi: 10.1371/journal.pone.0032296 pubmed: 22389693 pmcid: 3289650

Lee JH, You HJ, Lee TY et al (2022) Current status of experimental animal skin flap models: ischemic preconditioning and molecular factors. Int J Mol Sci. https://doi.org/10.3390/ijms23095234

doi: 10.3390/ijms23095234 pubmed: 36614165 pmcid: 9821412

Ruze A, Chen BD, Liu F et al (2019) Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection. Clin Sci (Lond) 133(5):665–680. https://doi.org/10.1042/CS20181013

doi: 10.1042/CS20181013 pubmed: 30804219

Cutrn JC, Perrelli MG, Cavalieri B et al (2002) Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 33(9):1200–1208. https://doi.org/10.1016/s0891-5849(02)01017-1

doi: 10.1016/s0891-5849(02)01017-1 pubmed: 12398928

Lin WY, Chang YC, Ho CJ et al (2013) Ischemic preconditioning reduces neurovascular damage after hypoxia-ischemia via the cellular inhibitor of apoptosis 1 in neonatal brain. Stroke 44(1):162–169. https://doi.org/10.1161/STROKEAHA.112.677617

doi: 10.1161/STROKEAHA.112.677617 pubmed: 23192759

Zhao ZQ, Corvera JS, Halkos ME et al (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579-588. https://doi.org/10.1152/ajpheart.01064.2002

doi: 10.1152/ajpheart.01064.2002 pubmed: 12860564

You J, Feng L, Xin M et al (2018) Cerebral ischemic postconditioning plays a neuroprotective role through regulation of central and peripheral glutamate. Biomed Res Int 2018:6316059. https://doi.org/10.1155/2018/6316059

doi: 10.1155/2018/6316059 pubmed: 30112410 pmcid: 6077516

Guo L, Xu JM, Mo XY (2015) Ischemic postconditioning regulates cardiomyocyte autophagic activity following ischemia/reperfusion injury. Mol Med Rep 12(1):1169–1176. https://doi.org/10.3892/mmr.2015.3533

doi: 10.3892/mmr.2015.3533 pubmed: 25816157

Dong M, Mu N, Guo F et al (2014) The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction. J Thromb Thrombolysis 38(2):208–214. https://doi.org/10.1007/s11239-013-1010-0

doi: 10.1007/s11239-013-1010-0 pubmed: 24249309

Li CY, Ma W, Liu KP et al (2021) Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning. Metab Brain Dis 36(1):53–65. https://doi.org/10.1007/s11011-020-00562-x

doi: 10.1007/s11011-020-00562-x pubmed: 33044640

Liu C, Yang J, Zhang C et al (2020) Remote ischemic conditioning reduced cerebral ischemic injury by modulating inflammatory responses and ERK activity in type 2 diabetic mice. Neurochem Int 135:104690. https://doi.org/10.1016/j.neuint.2020.104690

doi: 10.1016/j.neuint.2020.104690 pubmed: 31981607

Zhou CC, Yao WT, Ge YZ et al (2017) Remote ischemic conditioning for the prevention of contrast-induced acute kidney injury in patients undergoing intravascular contrast administration: a meta-analysis and trial sequential analysis of 16 randomized controlled trials. Oncotarget 8(45):79323–79336. https://doi.org/10.18632/oncotarget.18106

doi: 10.18632/oncotarget.18106 pubmed: 29108311 pmcid: 5668044

Min F, Jia XJ, Gao Q et al (2020) Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathway. Exp Ther Med 19(1):99–106. https://doi.org/10.3892/etm.2019.8176

doi: 10.3892/etm.2019.8176 pubmed: 31853278

Sluijter JPG, Davidson SM, Boulanger CM et al (2018) Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 114(1):19–34. https://doi.org/10.1093/cvr/cvx211

doi: 10.1093/cvr/cvx211 pubmed: 29106545

Loyer X, Vion AC, Tedgui A et al (2014) Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 114(2):345–353. https://doi.org/10.1161/CIRCRESAHA.113.300858

doi: 10.1161/CIRCRESAHA.113.300858 pubmed: 24436430

Boulanger CM, Scoazec A, Ebrahimian T et al (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104(22):2649–2652. https://doi.org/10.1161/hc4701.100516

doi: 10.1161/hc4701.100516 pubmed: 11723013

Porto I, Biasucci LM, De Maria GL et al (2012) Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 33(23):2928–2938. https://doi.org/10.1093/eurheartj/ehs065

doi: 10.1093/eurheartj/ehs065 pubmed: 22453653

Baranyai T, Giricz Z, Varga ZV et al (2017) In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature. J Transl Med 15(1):67. https://doi.org/10.1186/s12967-017-1166-z

doi: 10.1186/s12967-017-1166-z pubmed: 28364777 pmcid: 5376486

White SK, Frohlich GM, Sado DM et al (2015) Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 8(1 Pt B):178–188. https://doi.org/10.1016/j.jcin.2014.05.015

doi: 10.1016/j.jcin.2014.05.015 pubmed: 25240548

Eitel I, Stiermaier T, Rommel KP et al (2015) Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur Heart J 36(44):3049–3057. https://doi.org/10.1093/eurheartj/ehv463

doi: 10.1093/eurheartj/ehv463 pubmed: 26385956

Goerg J, Sommerfeld M, Greiner B et al (2021) Low-Dose empagliflozin improves systolic heart function after myocardial infarction in rats: regulation of MMP9, NHE1, and SERCA2a. Int J Mol Sci. https://doi.org/10.3390/ijms22115437

doi: 10.3390/ijms22115437 pubmed: 34063987 pmcid: 8196699

Wright EM, Loo DD, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91(2):733–794. https://doi.org/10.1152/physrev.00055.2009

doi: 10.1152/physrev.00055.2009 pubmed: 21527736

Sinha B, Ghosal S (2019) Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) reduce hospitalization for heart failure only and have no effect on atherosclerotic cardiovascular events: a meta-analysis. Diabetes Ther 10(3):891–899. https://doi.org/10.1007/s13300-019-0597-3

doi: 10.1007/s13300-019-0597-3 pubmed: 30875065 pmcid: 6531596

Mahaffey KW, Neal B, Perkovic V et al (2018) Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Circulation 137(4):323–334. https://doi.org/10.1161/CIRCULATIONAHA.117.032038

doi: 10.1161/CIRCULATIONAHA.117.032038 pubmed: 29133604 pmcid: 5777572

Wiviott SD, Raz I, Bonaca MP et al (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380(4):347–357. https://doi.org/10.1056/NEJMoa1812389

doi: 10.1056/NEJMoa1812389 pubmed: 30415602

Norhammar A, Bodegard J, Nystrom T et al (2019) Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: a nationwide observational study. Diabetes Obes Metab 21(5):1136–1145. https://doi.org/10.1111/dom.13627

doi: 10.1111/dom.13627 pubmed: 30609272 pmcid: 6593417

Fathi A, Vickneson K, Singh JS (2021) SGLT2-inhibitors; more than just glycosuria and diuresis. Heart Fail Rev 26(3):623–642. https://doi.org/10.1007/s10741-020-10038-w

doi: 10.1007/s10741-020-10038-w pubmed: 33274396

Ceriello A, Ofstad AP, Zwiener I et al (2020) Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial. Cardiovasc Diabetol 19(1):176. https://doi.org/10.1186/s12933-020-01147-9

doi: 10.1186/s12933-020-01147-9 pubmed: 33050931 pmcid: 7556977

Park SH, Belcastro E, Hasan H et al (2021) Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins. Cardiovasc Diabetol 20(1):65. https://doi.org/10.1186/s12933-021-01252-3

doi: 10.1186/s12933-021-01252-3 pubmed: 33726768 pmcid: 7967961

Ma L, Zou R, Shi W et al (2022) SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways. Theranostics 12(11):5034–5050. https://doi.org/10.7150/thno.75121

doi: 10.7150/thno.75121 pubmed: 35836807 pmcid: 9274739

Tian J, Zhang M, Suo M et al (2021) Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKalpha/TGF-beta/Smad signalling in type 2 diabetic rats. J Cell Mol Med 25(16):7642–7659. https://doi.org/10.1111/jcmm.16601

doi: 10.1111/jcmm.16601 pubmed: 34169635 pmcid: 8358881

Kolijn D, Pabel S, Tian Y et al (2021) Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Galpha oxidation. Cardiovasc Res 117(2):495–507. https://doi.org/10.1093/cvr/cvaa123

doi: 10.1093/cvr/cvaa123 pubmed: 32396609

Aragon-Herrera A, Feijoo-Bandin S, Anido-Varela L et al (2022) Relaxin-2 as a potential biomarker in cardiovascular diseases. J Pers Med. https://doi.org/10.3390/jpm12071021

doi: 10.3390/jpm12071021 pubmed: 35887517 pmcid: 9317583

Du XJ, Bathgate RA, Samuel CS et al (2010) Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 7(1):48–58. https://doi.org/10.1038/nrcardio.2009.198

doi: 10.1038/nrcardio.2009.198 pubmed: 19935741

Samuel CS, Du XJ, Bathgate RA et al (2006) “Relaxin” the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol Ther 112(2):529–552. https://doi.org/10.1016/j.pharmthera.2005.05.012

doi: 10.1016/j.pharmthera.2005.05.012 pubmed: 16814863

Bathgate RA, Halls ML, van der Westhuizen ET et al (2013) Relaxin family peptides and their receptors. Physiol Rev 93(1):405–480. https://doi.org/10.1152/physrev.00001.2012

doi: 10.1152/physrev.00001.2012 pubmed: 23303914

Hsu SY, Nakabayashi K, Nishi S et al (2002) Activation of orphan receptors by the hormone relaxin. Science 295(5555):671–674. https://doi.org/10.1126/science.1065654

doi: 10.1126/science.1065654 pubmed: 11809971

Martin B, Romero G, Salama G (2019) Cardioprotective actions of relaxin. Mol Cell Endocrinol 487:45–53. https://doi.org/10.1016/j.mce.2018.12.016

doi: 10.1016/j.mce.2018.12.016 pubmed: 30625345

Pini A, Boccalini G, Baccari MC et al (2016) Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin). J Cell Mol Med 20(5):891–902. https://doi.org/10.1111/jcmm.12802

doi: 10.1111/jcmm.12802 pubmed: 26915460 pmcid: 4831370

Gao S, Li L, Li L et al (2019) Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice. J Mol Cell Cardiol 137:59–70. https://doi.org/10.1016/j.yjmcc.2019.09.012

doi: 10.1016/j.yjmcc.2019.09.012 pubmed: 31629735

Uto T, Tung NH, Ohta T et al (2018) Antiproliferative activity and apoptosis induction by trijuganone C isolated from the root of Salvia miltiorrhiza Bunge (Danshen). Phytother Res 32(4):657–666. https://doi.org/10.1002/ptr.6013

doi: 10.1002/ptr.6013 pubmed: 29464799

Zhou R, He LF, Li YJ et al (2012) Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. J Ethnopharmacol 139(2):440–446. https://doi.org/10.1016/j.jep.2011.11.030

doi: 10.1016/j.jep.2011.11.030 pubmed: 22138518

Irmak F, Kurt Yazar S, Sirvan SS et al (2018) Beneficial effects of Salvia miltiorrhiza in the healing of burn wounds: an experimental study in rats. J Plast Surg Hand Surg 52(4):229–233. https://doi.org/10.1080/2000656X.2018.1461631

doi: 10.1080/2000656X.2018.1461631 pubmed: 29656662

Fei YX, Wang SQ, Yang LJ et al (2017) Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol 207:57–66. https://doi.org/10.1016/j.jep.2017.06.023

doi: 10.1016/j.jep.2017.06.023 pubmed: 28645780

Guo R, Li L, Su J et al (2020) Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Des Devel Ther 14:4735–4748. https://doi.org/10.2147/DDDT.S266911

doi: 10.2147/DDDT.S266911 pubmed: 33192051 pmcid: 7653026

Hung YC, Pan TL, Hu WL (2016) Roles of reactive oxygen species in anticancer therapy with Salvia miltiorrhiza bunge. Oxid Med Cell Longev 2016:5293284. https://doi.org/10.1155/2016/5293284

doi: 10.1155/2016/5293284 pubmed: 27579153 pmcid: 4989081

Chen L, Guo QH, Chang Y et al (2017) Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia. Cardiovasc Pathol 31:47–53. https://doi.org/10.1016/j.carpath.2017.06.008

doi: 10.1016/j.carpath.2017.06.008 pubmed: 28985491

Mo J, Yang R, Li F et al (2018) Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation. Phytomedicine 42:66–74. https://doi.org/10.1016/j.phymed.2018.03.021

doi: 10.1016/j.phymed.2018.03.021 pubmed: 29655699

Xi J, Rong Y, Zhao Z et al (2021) Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy. J Ethnopharmacol 271:113855. https://doi.org/10.1016/j.jep.2021.113855

doi: 10.1016/j.jep.2021.113855 pubmed: 33485979

Mondal NK, Behera J, Kelly KE et al (2019) Tetrahydrocurcumin epigenetically mitigates mitochondrial dysfunction in brain vasculature during ischemic stroke. Neurochem Int 122:120–138. https://doi.org/10.1016/j.neuint.2018.11.015

doi: 10.1016/j.neuint.2018.11.015 pubmed: 30472160

Vacek JC, Behera J, George AK et al (2018) Tetrahydrocurcumin ameliorates homocysteine-mediated mitochondrial remodeling in brain endothelial cells. J Cell Physiol 233(4):3080–3092. https://doi.org/10.1002/jcp.26145

doi: 10.1002/jcp.26145 pubmed: 28833102

Duan H, Zhang Q, Liu J et al (2021) Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacol Res 168:105599. https://doi.org/10.1016/j.phrs.2021.105599

doi: 10.1016/j.phrs.2021.105599

Li MT, Ke J, Guo SF et al (2021) The protective effect of quercetin on endothelial cells injured by hypoxia and reoxygenation. Front Pharmacol 12:732874. https://doi.org/10.3389/fphar.2021.732874

doi: 10.3389/fphar.2021.732874 pubmed: 34744717 pmcid: 8564287

Ahrens I, Peter K (2009) FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Curr Opin Investig Drugs 10(9): 997–1003. https://www.ncbi.nlm.nih.gov/pubmed/19705343 . Accessed 17 Aug 2023

Petzelbauer P, Zacharowski PA, Miyazaki Y et al (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11(3):298–304. https://doi.org/10.1038/nm1198

doi: 10.1038/nm1198 pubmed: 15723073

Kim DY, Zhang H, Park S et al (2020) CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury. J Mol Med (Berl) 98(6):875–886. https://doi.org/10.1007/s00109-020-01920-z

doi: 10.1007/s00109-020-01920-z pubmed: 32415357

Zhang H, Park JH, Maharjan S et al (2017) Sac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation. J Neuroinflammation 14(1):122. https://doi.org/10.1186/s12974-017-0897-3

doi: 10.1186/s12974-017-0897-3 pubmed: 28645333 pmcid: 5481915

Noh M, Kim Y, Zhang H et al (2023) Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases. Eur J Pharmacol 939:175427. https://doi.org/10.1016/j.ejphar.2022.175427

doi: 10.1016/j.ejphar.2022.175427 pubmed: 36509133

Park S, Oh JH, Park DJ et al (2020) CU06-1004-induced vascular normalization improves immunotherapy by modulating tumor microenvironment via cytotoxic T cells. Front Immunol 11:620166. https://doi.org/10.3389/fimmu.2020.620166

doi: 10.3389/fimmu.2020.620166 pubmed: 33584714

Shen J, Frye M, Lee BL et al (2014) Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest 124(10):4564–4576. https://doi.org/10.1172/JCI74527

doi: 10.1172/JCI74527 pubmed: 25180601 pmcid: 4191011

Shi Y, Xiong Y, Lei Y et al (2019) Protective effect of COMP-angiopoietin-1 on peritoneal vascular permeability and peritoneal transport function in uremic peritoneal dialysis rats. Am J Transl Res 11(9): 5932–5943. https://www.ncbi.nlm.nih.gov/pubmed/31632561 . Accessed 19 Aug 2023

Poirier B, Briand V, Kadereit D et al (2020) A G protein-biased S1P(1) agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Sci Signal. https://doi.org/10.1126/scisignal.aax8050

doi: 10.1126/scisignal.aax8050 pubmed: 32487716

Vaidya K, Tucker B, Patel S et al (2021) Acute Coronary Syndromes (ACS)-unravelling biology to identify new therapies-the microcirculation as a frontier for new therapies in ACS. Cells. https://doi.org/10.3390/cells10092188

doi: 10.3390/cells10092188 pubmed: 34571836 pmcid: 8468909

Matter MA, Paneni F, Libby P et al (2023) Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur Heart J. https://doi.org/10.1093/eurheartj/ehad486

doi: 10.1093/eurheartj/ehad486 pubmed: 37587550

Zhang Y, Wang S, Chen X et al (2022) Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy. Mol Cell Endocrinol 545:111560. https://doi.org/10.1016/j.mce.2022.111560

doi: 10.1016/j.mce.2022.111560 pubmed: 35032624

Chen Z, Wu H, Yang J et al (2022) Activating Parkin-dependent mitophagy alleviates oxidative stress, apoptosis, and promotes random-pattern skin flaps survival. Commun Biol 5(1):616. https://doi.org/10.1038/s42003-022-03556-w

doi: 10.1038/s42003-022-03556-w pubmed: 35732814 pmcid: 9217959

Liu N, Wu J, Zhang L et al (2017) Hydrogen Sulphide modulating mitochondrial morphology to promote mitophagy in endothelial cells under high-glucose and high-palmitate. J Cell Mol Med 21(12):3190–3203. https://doi.org/10.1111/jcmm.13223

doi: 10.1111/jcmm.13223 pubmed: 28608965 pmcid: 5706497

Zhou ZY, Shi WT, Zhang J et al (2023) Sodium tanshinone IIA sulfonate protects against hyperhomocysteine-induced vascular endothelial injury via activation of NNMT/SIRT1-mediated NRF2/HO-1 and AKT/MAPKs signaling in human umbilical vascular endothelial cells. Biomed Pharmacother 158:114137. https://doi.org/10.1016/j.biopha.2022.114137

doi: 10.1016/j.biopha.2022.114137 pubmed: 36525817

Jiang T, Liu T, Deng X et al (2021) Adiponectin ameliorates lung ischemia-reperfusion injury through SIRT1-PINK1 signaling-mediated mitophagy in type 2 diabetic rats. Respir Res 22(1):258. https://doi.org/10.1186/s12931-021-01855-0

doi: 10.1186/s12931-021-01855-0 pubmed: 34602075 pmcid: 8489101

Wang X, Zhang JQ, Xiu CK et al (2020) Ginseng-Sanqi-Chuanxiong (GSC) extracts ameliorate diabetes-induced endothelial cell senescence through regulating mitophagy via the AMPK pathway. Oxid Med Cell Longev 2020:7151946. https://doi.org/10.1155/2020/7151946

doi: 10.1155/2020/7151946 pubmed: 32963699 pmcid: 7495226

Hou Y, Wang XF, Lang ZQ et al (2018) Adiponectin is protective against endoplasmic reticulum stress-induced apoptosis of endothelial cells in sepsis. Braz J Med Biol Res 51(12):e7747. https://doi.org/10.1590/1414-431X20187747

doi: 10.1590/1414-431X20187747 pubmed: 30462773 pmcid: 6247242

Kapadia P, Bikkina P, Landicho MA et al (2021) Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells. Eur J Pharmacol 907:174249. https://doi.org/10.1016/j.ejphar.2021.174249

doi: 10.1016/j.ejphar.2021.174249 pubmed: 34116042

Li P, Xie C, Zhong J et al (2021) Melatonin attenuates ox-LDL-induced endothelial dysfunction by reducing ER stress and inhibiting JNK/Mff SIgnaling. Oxid Med Cell Longev 2021:5589612. https://doi.org/10.1155/2021/5589612

doi: 10.1155/2021/5589612 pubmed: 33763168 pmcid: 7952160

Qi K, Li X, Geng Y et al (2018) Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-alpha pathway. PLoS ONE 13(6):e0198403. https://doi.org/10.1371/journal.pone.0198403

doi: 10.1371/journal.pone.0198403 pubmed: 29912977 pmcid: 6005559

Rubig E, Stypmann J, Van Slyke P et al (2016) The synthetic Tie2 agonist peptide vasculotide protects renal vascular barrier function in experimental acute kidney injury. Sci Rep 6:22111. https://doi.org/10.1038/srep22111

doi: 10.1038/srep22111 pubmed: 26911791 pmcid: 4766468

Shah R, Wilkins E, Nichols M et al (2019) Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. Eur Heart J 40(9):755–764. https://doi.org/10.1093/eurheartj/ehy378

doi: 10.1093/eurheartj/ehy378 pubmed: 30124820

Collaborators GBDS (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0

doi: 10.1016/S1474-4422(21)00252-0

Pohl M, Hesszenberger D, Kapus K et al (2021) Ischemic stroke mimics: a comprehensive review. J Clin Neurosci 93:174–182. https://doi.org/10.1016/j.jocn.2021.09.025

doi: 10.1016/j.jocn.2021.09.025 pubmed: 34656244

Collaborators GBDCoD, (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1151–1210. https://doi.org/10.1016/S0140-6736(17)32152-9

doi: 10.1016/S0140-6736(17)32152-9

White BC, Sullivan JM, DeGracia DJ et al (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179(S1–2):1–33. https://doi.org/10.1016/s0022-510x(00)00386-5

doi: 10.1016/s0022-510x(00)00386-5 pubmed: 11054482

Puig B, Brenna S, Magnus T (2018) Molecular Communication of a Dying Neuron in Stroke. Int J Mol Sci. https://doi.org/10.3390/ijms19092834

doi: 10.3390/ijms19092834 pubmed: 30322103 pmcid: 6213377

Yoon JS, Jo D, Lee HS et al (2018) Spatiotemporal protein atlas of cell death-related molecules in the rat MCAO stroke model. Exp Neurobiol 27(4):287–298. https://doi.org/10.5607/en.2018.27.4.287

doi: 10.5607/en.2018.27.4.287 pubmed: 30181691 pmcid: 6120968

Pan J, Konstas AA, Bateman B et al (2007) Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 49(2):93–102. https://doi.org/10.1007/s00234-006-0183-z

doi: 10.1007/s00234-006-0183-z pubmed: 17177065

Sun MS, Jin H, Sun X et al (2018) Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev 2018:3804979. https://doi.org/10.1155/2018/3804979

doi: 10.1155/2018/3804979 pubmed: 29770166 pmcid: 5892600

Imai T, Matsubara H, Nakamura S et al (2020) The mitochondria-targeted peptide, bendavia, attenuated ischemia/reperfusion-induced stroke damage. Neuroscience 443:110–119. https://doi.org/10.1016/j.neuroscience.2020.07.044

doi: 10.1016/j.neuroscience.2020.07.044 pubmed: 32738431

Yang D, Li Z, Gao G et al (2021) Combined analysis of surface protein profile and microRNA expression profile of exosomes derived from brain microvascular endothelial cells in early cerebral ischemia. ACS Omega 6(34):22410–22421. https://doi.org/10.1021/acsomega.1c03248

doi: 10.1021/acsomega.1c03248 pubmed: 34497930 pmcid: 8412952

Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329. https://doi.org/10.1056/NEJMoa0804656

doi: 10.1056/NEJMoa0804656 pubmed: 18815396

Emberson J, Lees KR, Lyden P et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384(9958):1929–1935. https://doi.org/10.1016/S0140-6736(14)60584-5

doi: 10.1016/S0140-6736(14)60584-5 pubmed: 25106063 pmcid: 4441266

Lees KR, Emberson J, Blackwell L et al (2016) Effects of Alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke 47(9):2373–2379. https://doi.org/10.1161/STROKEAHA.116.013644

doi: 10.1161/STROKEAHA.116.013644 pubmed: 27507856 pmcid: 5024752

Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X

doi: 10.1016/S0140-6736(16)00163-X pubmed: 26898852

Kim JS (2019) tPA helpers in the treatment of acute ischemic stroke: are they ready for clinical use? J Stroke 21(2):160–174. https://doi.org/10.5853/jos.2019.00584

doi: 10.5853/jos.2019.00584 pubmed: 31161761 pmcid: 6549064

Tsuji K, Aoki T, Tejima E et al (2005) Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36(9):1954–1959. https://doi.org/10.1161/01.STR.0000177517.01203.eb

doi: 10.1161/01.STR.0000177517.01203.eb pubmed: 16051896

Montaner J, Molina CA, Monasterio J et al (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107(4):598–603. https://doi.org/10.1161/01.cir.0000046451.38849.90

doi: 10.1161/01.cir.0000046451.38849.90 pubmed: 12566373

Mueller-Kronast NH, Zaidat OO, Froehler MT et al (2017) Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS Registry. Stroke 48(10):2760–2768. https://doi.org/10.1161/STROKEAHA.117.016456

doi: 10.1161/STROKEAHA.117.016456 pubmed: 28830971

Puentes S, Kurachi M, Shibasaki K et al (2012) Brain microvascular endothelial cell transplantation ameliorates ischemic white matter damage. Brain Res 1469:43–53. https://doi.org/10.1016/j.brainres.2012.06.042

doi: 10.1016/j.brainres.2012.06.042 pubmed: 22771710

Zimmet P, Alberti KG, Magliano DJ et al (2016) Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 12(10):616–622. https://doi.org/10.1038/nrendo.2016.105

doi: 10.1038/nrendo.2016.105 pubmed: 27388988

Sun H, Saeedi P, Karuranga S et al (2022) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119

doi: 10.1016/j.diabres.2021.109119 pubmed: 34879977

Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88–98. https://doi.org/10.1038/nrendo.2017.151

doi: 10.1038/nrendo.2017.151 pubmed: 29219149

Kocak MZ, Aktas G, Atak BM et al (2020) Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest 50(3):e13206. https://doi.org/10.1111/eci.13206

doi: 10.1111/eci.13206 pubmed: 31999832

Ozgumus T, Sulaieva O, Jessen LE et al (2021) Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes: the PROLONG study. Sci Rep 11(1):20735. https://doi.org/10.1038/s41598-021-00183-z

doi: 10.1038/s41598-021-00183-z pubmed: 34671071 pmcid: 8528906

Xue P, Covassin N, Ran X et al (2020) Association of parameters of nocturnal hypoxemia with diabetic microvascular complications: a cross-sectional study. Diabetes Res Clin Pract 170:108484. https://doi.org/10.1016/j.diabres.2020.108484

doi: 10.1016/j.diabres.2020.108484 pubmed: 33031843

Vincent AM, Callaghan BC, Smith AL et al (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 7(10):573–583. https://doi.org/10.1038/nrneurol.2011.137

doi: 10.1038/nrneurol.2011.137 pubmed: 21912405

Imamura Y, Suzuki K, Saijo H et al (2022) Longitudinal physiological remoulding of lower limb skin as a cause of diabetic foot ulcer: a histopathological examination. J Wound Care 31(Sup8):S29–S35. https://doi.org/10.12968/jowc.2022.31.Sup8.S29

doi: 10.12968/jowc.2022.31.Sup8.S29 pubmed: 36004943

Yang S, Ma C, Wu H et al (2020) Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway. Pharmacol Res 153:104678. https://doi.org/10.1016/j.phrs.2020.104678

doi: 10.1016/j.phrs.2020.104678 pubmed: 32014572

Zhang Z, Yang Z, Zhu B et al (2012) Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS ONE 7(11):e49128. https://doi.org/10.1371/journal.pone.0049128

doi: 10.1371/journal.pone.0049128 pubmed: 23185302 pmcid: 3501497

Toth E, Racz A, Toth J et al (2007) Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation. Am J Physiol Heart Circ Physiol 293(5):H3096-3104. https://doi.org/10.1152/ajpheart.01335.2006

doi: 10.1152/ajpheart.01335.2006 pubmed: 17873009

Kielbik M, Szulc-Kielbik I, Klink M (2019) The potential role of iNOS in ovarian cancer progression and chemoresistance. Int J Mol Sci. https://doi.org/10.3390/ijms20071751

doi: 10.3390/ijms20071751 pubmed: 30970628 pmcid: 6479373

Pei H, Yang Y, Cui L et al (2016) Bisdemethoxycurcumin inhibits ovarian cancer via reducing oxidative stress mediated MMPs expressions. Sci Rep 6:28773. https://doi.org/10.1038/srep28773

doi: 10.1038/srep28773 pubmed: 27349797 pmcid: 4923879

Lv H, Cheng Q, Li Y et al (2021) The protective effects of ropivacaine against high glucose-induced brain microvascular endothelial injury by reducing mmps and alleviating oxidative stress. Neurotox Res 39(3):851–859. https://doi.org/10.1007/s12640-020-00324-8

doi: 10.1007/s12640-020-00324-8 pubmed: 33538995

Molitoris BA (2014) Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest 124(6):2355–2363. https://doi.org/10.1172/JCI72269

doi: 10.1172/JCI72269 pubmed: 24892710 pmcid: 4089444

Yang B, Lan S, Dieude M et al (2018) Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia-reperfusion injury. J Am Soc Nephrol 29(7):1900–1916. https://doi.org/10.1681/ASN.2017050581

doi: 10.1681/ASN.2017050581 pubmed: 29925521 pmcid: 6050936

Doreille A, Dieude M, Cardinal H (2019) The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients. Am J Physiol Renal Physiol 316(1):F9–F19. https://doi.org/10.1152/ajprenal.00163.2018

doi: 10.1152/ajprenal.00163.2018 pubmed: 30379097

Babickova J, Klinkhammer BM, Buhl EM et al (2017) Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney Int 91(1):70–85. https://doi.org/10.1016/j.kint.2016.07.038

doi: 10.1016/j.kint.2016.07.038 pubmed: 27678159

Farris AB, Taheri D, Kawai T et al (2011) Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant 11(7):1464–1477. https://doi.org/10.1111/j.1600-6143.2011.03572.x

doi: 10.1111/j.1600-6143.2011.03572.x pubmed: 21668634 pmcid: 3128680

Furuichi K, Wada T, Kaneko S et al (2008) Roles of chemokines in renal ischemia/reperfusion injury. Front Biosci 13:4021–4028. https://doi.org/10.2741/2990

doi: 10.2741/2990 pubmed: 18508496

Higgins DF, Kimura K, Bernhardt WM et al (2007) Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117(12):3810–3820. https://doi.org/10.1172/JCI30487

doi: 10.1172/JCI30487 pubmed: 18037992 pmcid: 2082142

Camacho X, Nedkoff L, Wright FL et al (2022) Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1.95 million events in 80.4 million people in four countries. Lancet Public Health 7(3):e229–e239. https://doi.org/10.1016/S2468-2667(22)00006-8

doi: 10.1016/S2468-2667(22)00006-8 pubmed: 35247353

Frantz S, Hundertmark MJ, Schulz-Menger J et al (2022) Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43(27):2549–2561. https://doi.org/10.1093/eurheartj/ehac223

doi: 10.1093/eurheartj/ehac223 pubmed: 35511857 pmcid: 9336586

Zhou H, Wang S, Zhu P et al (2018) Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission. Redox Biol 15:335–346. https://doi.org/10.1016/j.redox.2017.12.019

doi: 10.1016/j.redox.2017.12.019 pubmed: 29306791

Tan Y, Mui D, Toan S et al (2020) SERCA overexpression improves mitochondrial quality control and attenuates cardiac microvascular ischemia-reperfusion injury. Mol Ther Nucleic Acids 22:696–707. https://doi.org/10.1016/j.omtn.2020.09.013

doi: 10.1016/j.omtn.2020.09.013 pubmed: 33230467 pmcid: 7585837

The role and mechanisms of microvascular damage in the ischemic myocardium.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Subventions

Informations de copyright

Références

Auteurs

Bang-Hao Zhao (BH)

Amanguli Ruze (A)

Ling Zhao (L)

Qiu-Lin Li (QL)

Jing Tang (J)

Nilupaer Xiefukaiti (N)

Min-Tao Gai (MT)

An-Xia Deng (AX)

Xue-Feng Shan (XF)

Xiao-Ming Gao (XM)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH